From: Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin
IHC panel | Subtype | Diagnostic criteria* | ||
---|---|---|---|---|
At least one positive (n/%) | At least two positive (n/%) | All three positive (n/%) | ||
GATA3, MGP | ER/PR+ | 556 (98.4) | 478 (84.6) | – |
HER2+ | 344 (97.7) | 248 (70.5) | – | |
TNBC-NSTs | 131 (91.0) | 50 (34.7) | – | |
TNBC-MBCs | 130 (92.9) | 60 (42.9) | – | |
Total | 1161 (96.7) | 836 (69.6) | – | |
GATA3, TRPS1 | ER/PR+ | 558 (98.8) | 496 (87.8) | – |
HER2+ | 335 (95.2) | 260 (73.9) | – | |
TNBC-NSTs | 125 (86.8) | 54 (37.5) | – | |
TNBC-MBCs | 138 (98.6) | 65 (46.4) | – | |
Total | 1156 (96.3) | 875 (72.9) | – | |
MGP, TRPS1 | ER/PR+ | 557 (98.6) | 475 (84.1) | – |
HER2+ | 349 (99.1) | 296 (84.1) | – | |
TNBC-NSTs | 139 (96.5) | 107 (74.3) | – | |
TNBC-MBCs | 139 (99.3) | 122 (87.1) | – | |
Total | 1184 (98.6) | 1000 (83.3) | – | |
GATA3, MGP, TRPS1 | ER/PR+ | 563 (99.6) | 545 (96.5) | 452 (80.0) |
HER2+ | 350 (99.4) | 328 (93.2) | 238 (67.6) | |
TNBC-NSTs | 139 (96.5) | 117 (81.3) | 47 (32.6) | |
TNBC-MBCs | 140 (100.0) | 127 (90.7) | 60 (42.9) | |
Total | 1192 (99.3) | 1117 (93.0) | 797 (66.4) |